Showing 1 - 5 results of 5 for search 'Johannes Beeslaar', query time: 0.03s
Refine Results
-
1
Modeling excess zeroes in an integrated analysis of vaccine safety by Roger Maansson, David Radley, Qin Jiang, Johannes Beeslaar, Scott Patterson, Judith Absalon, John Perez
Published 2018-06-01
Article -
2
-
3
Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data by Johannes Beeslaar, Paula Peyrani, Judith Absalon, Jason Maguire, Joseph Eiden, Paul Balmer, Roger Maansson, John L. Perez
Published 2020-07-01
Article -
4
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine by John L. Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U. Jansen, Thomas R. Jones, Shannon Harris, Laura J. York, Qin Jiang, David Radley, Annaliesa S. Anderson, Graham Crowther, Joseph J. Eiden
Published 2018-06-01
Article -
5
MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies by Johannes Beeslaar, Judith Absalon, Annaliesa S. Anderson, Joseph J. Eiden, Paul Balmer, Shannon L. Harris, Thomas R. Jones, Robert E. O’Neill, Jean-Louis Pregaldien, David Radley, Roger Maansson, John Ginis, Amit Srivastava, John L. Perez
Published 2020-07-01
Article